Skip to main content
. 2020 Feb 6;10(2):14. doi: 10.1038/s41408-020-0283-8

Fig. 2. Kaplan−Meier curves comparing PFS for IGHD4 and IGHD2/3 users in transplant-ineligible patients.

Fig. 2

Survival curves compare progression-free survival rates between IGHD4 (a) or IGHD2/IGHD3 users (b) and other IGHD users. IGHD4 users are represented in red, while IGHD2/IGHD3 users are represented in black in their respective plots. Patients at risk at each time point appear below each plot.